Sun Pharma Incorporates US Subsidiary Sun Pharma America

Sun Pharmaceutical Industries incorporated a new 100% subsidiary, Sun Pharma America, Inc., in the United States on April 23, 2026.
The incorporation is for internal group structuring purposes and falls within Sun Pharma's main pharmaceutical business line.
The transaction involved an initial cash consideration and does not constitute a related party transaction.
This disclosure is made under SEBI Listing Regulations as a material subsidiary incorporation event.